Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Evaluation of response to lapatinib in patients with HER2-positive metastatic breast cancer using FDG-PET

Evaluation of response to lapatinib in patients with HER2-positive metastatic breast cancer using FDG-PET. Breast Ca Res Treat. 2006; 100(Suppl 1):S67.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.